Literature DB >> 21448133

T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1.

Jens Staal1, Yasmine Driege, Tine Bekaert, Annelies Demeyer, David Muyllaert, Petra Van Damme, Kris Gevaert, Rudi Beyaert.   

Abstract

The paracaspase mucosa-associated lymphoid tissue 1 (MALT1) is central to lymphocyte activation and lymphomagenesis. MALT1 mediates antigen receptor signalling to NF-κB by acting as a scaffold protein. Furthermore, MALT1 has proteolytic activity that contributes to optimal NF-κB activation by cleaving the NF-κB inhibitor A20. Whether MALT1 protease activity is involved in other signalling pathways, and the identity of the relevant substrates, is unknown. Here, we show that T-cell receptors (TCR) activation, as well as overexpression of the oncogenic API2-MALT1 fusion protein, results in proteolytic inactivation of CYLD by MALT1, which is specifically required for c-jun N-terminal kinase (JNK) activation and the inducible expression of a subset of genes. These results indicate a novel role for MALT1 proteolytic activity in TCR-induced JNK activation and reveal CYLD cleavage as the underlying mechanism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21448133      PMCID: PMC3101995          DOI: 10.1038/emboj.2011.85

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  50 in total

1.  NF-kappaB activation in T cells requires discrete control of IkappaB kinase alpha/beta (IKKalpha/beta) phosphorylation and IKKgamma ubiquitination by the ADAP adapter protein.

Authors:  Rupa Srivastava; Brandon J Burbach; Yoji Shimizu
Journal:  J Biol Chem       Date:  2010-02-17       Impact factor: 5.157

2.  Naturally occurring short splice variant of CYLD positively regulates dendritic cell function.

Authors:  Cathy Cecilia Srokowski; Joumana Masri; Nadine Hövelmeyer; Anna Katharina Krembel; Christine Tertilt; Dennis Strand; Karsten Mahnke; Ramin Massoumi; Ari Waisman; Hansjörg Schild
Journal:  Blood       Date:  2009-04-02       Impact factor: 22.113

Review 3.  A20: central gatekeeper in inflammation and immunity.

Authors:  Beatrice Coornaert; Isabelle Carpentier; Rudi Beyaert
Journal:  J Biol Chem       Date:  2008-11-13       Impact factor: 5.157

Review 4.  The role of scaffold proteins in JNK signalling.

Authors:  W Engström; A Ward; K Moorwood
Journal:  Cell Prolif       Date:  2009-11-17       Impact factor: 6.831

5.  The chaperone-like protein HYPK acts together with NatA in cotranslational N-terminal acetylation and prevention of Huntingtin aggregation.

Authors:  Thomas Arnesen; Kristian K Starheim; Petra Van Damme; Rune Evjenth; Huyen Dinh; Matthew J Betts; Anita Ryningen; Joël Vandekerckhove; Kris Gevaert; Dave Anderson
Journal:  Mol Cell Biol       Date:  2010-02-12       Impact factor: 4.272

6.  CARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells.

Authors:  Linda M McAllister-Lucas; Jürgen Ruland; Katy Siu; Xiaohong Jin; Shufang Gu; David S L Kim; Peter Kuffa; Dawn Kohrt; Tak W Mak; Gabriel Nuñez; Peter C Lucas
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-13       Impact factor: 11.205

7.  The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination.

Authors:  Andrew Kovalenko; Christine Chable-Bessia; Giuseppina Cantarella; Alain Israël; David Wallach; Gilles Courtois
Journal:  Nature       Date:  2003-08-14       Impact factor: 49.962

8.  Regulation of NF-kappaB-dependent lymphocyte activation and development by paracaspase.

Authors:  Astrid A Ruefli-Brasse; Dorothy M French; Vishva M Dixit
Journal:  Science       Date:  2003-10-23       Impact factor: 47.728

9.  Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains.

Authors:  David Komander; Francisca Reyes-Turcu; Julien D F Licchesi; Peter Odenwaelder; Keith D Wilkinson; David Barford
Journal:  EMBO Rep       Date:  2009-04-17       Impact factor: 8.807

10.  Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation.

Authors:  Jessica E Hutti; Rhine R Shen; Derek W Abbott; Alicia Y Zhou; Kam M Sprott; John M Asara; William C Hahn; Lewis C Cantley
Journal:  Mol Cell       Date:  2009-05-14       Impact factor: 17.970

View more
  96 in total

1.  Mechanism and specificity of the human paracaspase MALT1.

Authors:  Janna Hachmann; Scott J Snipas; Bram J van Raam; Erik M Cancino; Emily J Houlihan; Marcin Poreba; Paulina Kasperkiewicz; Marcin Drag; Guy S Salvesen
Journal:  Biochem J       Date:  2012-04-01       Impact factor: 3.857

2.  Malt1 protease inactivation efficiently dampens immune responses but causes spontaneous autoimmunity.

Authors:  Maike Jaworski; Ben J Marsland; Jasmine Gehrig; Werner Held; Stéphanie Favre; Sanjiv A Luther; Mai Perroud; Déla Golshayan; Olivier Gaide; Margot Thome
Journal:  EMBO J       Date:  2014-10-15       Impact factor: 11.598

3.  MALT1 is a critical mediator of PAR1-driven NF-κB activation and metastasis in multiple tumor types.

Authors:  Peter C Lucas; Linda M McAllister-Lucas; J Randall McAuley; Kelly M Bailey; Prasanna Ekambaram; Linda R Klei; Heejae Kang; Dong Hu; Tanner J Freeman; Vincent J Concel; Nathaniel E Hubel; Jia-Ying Lloyd Lee; Hanna B Klei; Jing Cheng; Preethiya Sekar; Rachel E Bridwell; Lidija Covic
Journal:  Oncogene       Date:  2019-08-16       Impact factor: 9.867

4.  The fructose-2,6-bisphosphatase TIGAR suppresses NF-κB signaling by directly inhibiting the linear ubiquitin assembly complex LUBAC.

Authors:  Yan Tang; Hyokjoon Kwon; Brian A Neel; Michal Kasher-Meron; Jacob B Pessin; Eijiro Yamada; Jeffrey E Pessin
Journal:  J Biol Chem       Date:  2018-04-12       Impact factor: 5.157

5.  Tumor suppressor cylindromatosis (CYLD) controls HIV transcription in an NF-κB-dependent manner.

Authors:  Lara Manganaro; Lars Pache; Tobias Herrmann; John Marlett; Young Hwang; Jeffrey Murry; Lisa Miorin; Adrian T Ting; Renate König; Adolfo García-Sastre; Frederic D Bushman; Sumit K Chanda; John A T Young; Ana Fernandez-Sesma; Viviana Simon
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

6.  miR-526a regulates apoptotic cell growth in human carcinoma cells.

Authors:  Xiaoli Yang; Cui Wang; Changzhi Xu; Zhifeng Yan; Congwen Wei; Kai Guan; Shengli Ma; Ye Cao; Liping Liu; Deyong Zou; Xiang He; Buchang Zhang; Qingjun Ma; Zirui Zheng
Journal:  Mol Cell Biochem       Date:  2015-05-23       Impact factor: 3.396

Review 7.  From MALT lymphoma to the CBM signalosome: three decades of discovery.

Authors:  Shaun Rosebeck; Aasia O Rehman; Peter C Lucas; Linda M McAllister-Lucas
Journal:  Cell Cycle       Date:  2011-08-01       Impact factor: 4.534

Review 8.  Metacaspases versus caspases in development and cell fate regulation.

Authors:  E A Minina; N S Coll; H Tuominen; P V Bozhkov
Journal:  Cell Death Differ       Date:  2017-02-24       Impact factor: 15.828

9.  MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivo.

Authors:  Lorena Fontan; Chenghua Yang; Venkataraman Kabaleeswaran; Laurent Volpon; Michael J Osborne; Elena Beltran; Monica Garcia; Leandro Cerchietti; Rita Shaknovich; Shao Ning Yang; Fang Fang; Randy D Gascoyne; Jose Angel Martinez-Climent; J Fraser Glickman; Katherine Borden; Hao Wu; Ari Melnick
Journal:  Cancer Cell       Date:  2012-12-11       Impact factor: 31.743

Review 10.  The Paracaspase MALT1.

Authors:  Janna Hachmann; Guy S Salvesen
Journal:  Biochimie       Date:  2015-09-16       Impact factor: 4.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.